Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study
Phase 1 results from a Phase 1/2 study comprise 18 patients with myelodysplastic syndromes myelodysplastic syndromes: (my-eh-
